Evaluation of balloon sinuplasty for the treatment of pediatric chronic rhinosinusitis.
| Autor: | Fadel MA; Texas Children's Hospital - Pediatric Otolaryngology-Head & Neck Surgery., Ramaswamy US; Texas Children's Hospital - Pediatric Otolaryngology-Head & Neck Surgery.; Texas Children's Hospital - Pediatric Neurosurgery, Baylor College of Medicine - Otolaryngology-Head & Neck Surgery, Houston, Texas, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Current opinion in otolaryngology & head and neck surgery [Curr Opin Otolaryngol Head Neck Surg] 2024 Dec 01; Vol. 32 (6), pp. 424-427. Date of Electronic Publication: 2024 Oct 11. |
| DOI: | 10.1097/MOO.0000000000001016 |
| Abstrakt: | Purpose of Review: This year marks 10 years from the publication of the clinical consensus statement on pediatric chronic rhinosinusitis (CRS). Balloon sinuplasty did not meet criteria for consensus at that time because there was insufficient evidence on its efficacy and safety. The purpose of this review is to summarize the current evidence on balloon sinuplasty treatment for pediatric CRS. Recent Findings: Balloon sinuplasty is not a cost-effective measure compared to adenoidectomy and endoscopic sinus surgery (ESS). In the pediatric population, benefits include short operative time, reduced tissue manipulation, and potential for decreased antibiotic courses. Alternatively, balloon dilation has increased equipment costs and there is a lack of robust prospective data that fully elucidates balloon sinuplasty's role in the management of pediatric CRS. Summary: Pediatric otolaryngologists should continue to perform first-line adenoidectomy and consider ESS based on imaging and other validated clinical scoring systems. Balloon sinuplasty has not yet been proven as an effective treatment for pediatric CRS and further large-scale investigations are required to overcome its lack of cost-effectiveness. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|